A case of disseminated Mycobacterium bovis 2 years post‐intravesicular Bacillus Calmette–Guérin therapy for superficial urinary bladder cancer
Disseminated Mycobacterium bovis is an uncommon side‐effect of intravesical Bacillus Calmette–Guérin (BCG) therapy that may be mediated through Mycobacteraemia. This case report, of a 77‐year‐old man with a history of intravesical BCG therapy and recent cardiac surgery, highlights the need for patie...
Saved in:
Published in | Internal medicine journal Vol. 47; no. 7; pp. 820 - 823 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Melbourne
John Wiley & Sons Australia, Ltd
01.07.2017
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disseminated Mycobacterium bovis is an uncommon side‐effect of intravesical Bacillus Calmette–Guérin (BCG) therapy that may be mediated through Mycobacteraemia. This case report, of a 77‐year‐old man with a history of intravesical BCG therapy and recent cardiac surgery, highlights the need for patients with similar features on history, presenting with generalised symptoms, to have mycobacterial cultures included in their workup. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 1444-0903 1445-5994 |
DOI: | 10.1111/imj.13475 |